Canadian Medical Community Embraces The Aura, Core!
Dr. Andrei Metelitsa, Institute for Skin Advancement, Calgary, Canada - "As a practising dermatologist, I see the growing need for a device such as Aura(TM) to better serve our patients. Clinical study results show the ability of Aura(TM) to efficiently assist in diagnosing skin cancer. Any tool that can be used to evaluate suspicious skin lesions quickly and accurately is a welcome addition to a dermatological practice."
Dr. Barry Lycka, Canadian Skin Cancer Foundation Edmonton, Canada – ”a new skin cancer detection device that is coming out that will help you if you have a skin cancer – it will help diagnose it early and quickly and is more reliable than previous methods to make skin cancer checks. The machine was invented in Canada and it’s being developed in British Columbia. The machine is called the “Aura” by Verisante and it’s phenomenal in what it can do.”
Dr. Harvey Lui, head and professor in the Department of Dermatology and Skin Science at the University of British Columbia and director of the world–renowned Skin Care Centre at VGH; Secretary General of 23rd World Congress of Dermatology - “With the current lack of tools available, diagnosing malignant melanoma – the most deadly form of skin cancer – can be challenging for even the most experienced dermatologist. Clearly, a new tool such as the Verisante Aura was desperately needed to improve patient care and detection procedures, and provide immediate diagnosis.”
Dr. Stephen Lam, MD, FRCPC, professor of medicine at the University of British Columbia, chair of the Lung Tumour Group and leader of the Lung Cancer Prevention Program at the BC Cancer Agency - “It is critically important to have an optical biopsy system such as the Verisante Core™ device to help make informed surgical decisions, because endoscopists and surgeons do not want to take unnecessary biopsies of lung tissue. For optimum patient health, benign lesions should be left alone.”
